100 Alumni of Influence

Home | Profiles by Year | Profiles by Name | Discussion Group

Dr. Calvin R. Stiller, C.M, O.Ont, MD’65

With more than 250 published papers, Calvin Stiller conducted the seminal study that established cyclosporine as foundational therapy in transplantation and demonstrated that human Type 1 Diabetes was amenable to immune therapy. He co-founded the Robarts Research Institute, The Canadian Medical Hall of Fame, the MARS Discovery District in Toronto, the Ontario Institute for Cancer Research, the Canadian Medical Discoveries Fund, and chaired a board responsible for over $1.2 billion of Ontario Government investment in University research. He is Chair of Genome Canada and serves on the board of several public companies.